33
Evolution of Parathyroid Surgery Using Sestamibi Imaging Guidance David R. Byrd, MD Department of Surgery University of Washington

Evolution of Parathyroid Surgery Using Sestamibi Imaging Guidance David R. Byrd, MD Department of Surgery University of Washington

  • View
    219

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Evolution of Parathyroid Surgery Using Sestamibi Imaging Guidance David R. Byrd, MD Department of Surgery University of Washington

Evolution of Parathyroid Surgery Using Sestamibi

Imaging Guidance

David R. Byrd, MD

Department of Surgery

University of Washington

Page 2: Evolution of Parathyroid Surgery Using Sestamibi Imaging Guidance David R. Byrd, MD Department of Surgery University of Washington

Disorders of Parathyroid Glands• hypoparathyroidism -rare. Almost always caused

by excessive surgical removal of parathyroid tissue (iatrogenic) during thyroid or parathyroid surgery

• hyperparathyroidism (HPT): – primary - hi Ca++, hi PTH - usually due to single

adenoma (90%), cured by removal of adenoma

– secondary - lo Ca++, hi PTH, seen in chronic renal failure - not a surgical problem

– tertiary - hi Ca++, hi PTH, seen after renal transplant - hyperplasia of all 4 glands

Page 3: Evolution of Parathyroid Surgery Using Sestamibi Imaging Guidance David R. Byrd, MD Department of Surgery University of Washington

Traditional Surgery for Hyperparathyroidism

• primary HPT - 4 gland exploration, remove adenoma, biopsy 3+ normal glands

• tertiary HPT (after renal transplantation) - 3 1/2 gland removal +/- forearm autotransplant

Page 4: Evolution of Parathyroid Surgery Using Sestamibi Imaging Guidance David R. Byrd, MD Department of Surgery University of Washington
Page 5: Evolution of Parathyroid Surgery Using Sestamibi Imaging Guidance David R. Byrd, MD Department of Surgery University of Washington
Page 6: Evolution of Parathyroid Surgery Using Sestamibi Imaging Guidance David R. Byrd, MD Department of Surgery University of Washington
Page 7: Evolution of Parathyroid Surgery Using Sestamibi Imaging Guidance David R. Byrd, MD Department of Surgery University of Washington

Complications of Parathyroid Surgery

• persistent HPT - 1-20% (experience dependent)• temporary or permanent hypocalcemia - 1-

20%• nerve injury - recurrent or superior laryngeal -

1-10%• bleeding - <5%

Page 8: Evolution of Parathyroid Surgery Using Sestamibi Imaging Guidance David R. Byrd, MD Department of Surgery University of Washington

Unilateral Exploration for Primary HPT

• if: one abnormal, hypercellular gland and one normal gland found on one side, no contralateral exploration

• occasional use of preop thallium-technetium scan

• results of 5 studies - cure 93-100%

Page 9: Evolution of Parathyroid Surgery Using Sestamibi Imaging Guidance David R. Byrd, MD Department of Surgery University of Washington

Indications for Operation in Asymptomatic Patient w/ Primary

HPT - NIH Consensus(1990)

• markedly elevated serum Ca++• episode of life-threatening hyperCa++• reduced creatinine clearance• renal stones• markedly elevated 24 hr urinary Ca++• substantially reduced bone mass (by DEXA

scan)• age <50 (relative indication for surgery)

Page 10: Evolution of Parathyroid Surgery Using Sestamibi Imaging Guidance David R. Byrd, MD Department of Surgery University of Washington

Parathyroid Imaging

• Tc-99m sestamibi scan (Cardiolyte)• ultrasound• initially thought useful only in persistent or

recurrent disease• thallium-technetium subtraction scan - now

rarely used

Page 11: Evolution of Parathyroid Surgery Using Sestamibi Imaging Guidance David R. Byrd, MD Department of Surgery University of Washington

Tc-99m Sestamibi Scan

• taken up by actively metabolizing tissues - salivary glands, thyroid, parathyroid glands

• over time, blood flow causes washout from thyroid and normal parathyroid glands

• delayed images show a discrete “hot spot” in 75-80% patients with primary HPT

• can be used to direct minimally invasive surgical approaches

Page 12: Evolution of Parathyroid Surgery Using Sestamibi Imaging Guidance David R. Byrd, MD Department of Surgery University of Washington

Parathyroid Imaging - Tc-99m Sestamibi45 min Anterior 45 min LAO

2 HR 2 HR

submandibulargland

thyroid lobe

adenoma

Delayedviews

Page 13: Evolution of Parathyroid Surgery Using Sestamibi Imaging Guidance David R. Byrd, MD Department of Surgery University of Washington

Right inferior pole parathyroid adenoma

15 min Ant 1 hr Ant 1 hr RAO

adenoma

Page 14: Evolution of Parathyroid Surgery Using Sestamibi Imaging Guidance David R. Byrd, MD Department of Surgery University of Washington

15 min Ant 1 hr Ant

Right superior parathyroid adenoma

adenoma

Page 15: Evolution of Parathyroid Surgery Using Sestamibi Imaging Guidance David R. Byrd, MD Department of Surgery University of Washington

Advances Enabling Localized Exploration

• Tc-99m sestamibi radioguided exploration

• rapid IOPTH assay - 1/2 life = 3-5 minutes

Page 16: Evolution of Parathyroid Surgery Using Sestamibi Imaging Guidance David R. Byrd, MD Department of Surgery University of Washington

Rapid IOPTH Assay

• exploits short half life (3-5 minutes) of PTH• serum baseline level #1 prior to exploration• level #2 after exploration but before removal

adenoma• levels 5 & 10 minutes after adenoma removal• 5 minute level > 50% second baseline level =

high prediction of success-Irvin G, et al, 1993

Page 17: Evolution of Parathyroid Surgery Using Sestamibi Imaging Guidance David R. Byrd, MD Department of Surgery University of Washington

Studies of IOPTH Measurement in HPT

solitary/ Uni/bilat. Cure rate # pts MGD exploration ( %)

Nussbaum 1988 12 12/0 8/4 100Chapuis 1996 173 -- 160/13 94Irvin 1993 61 -- -- 90Sofferman 1998 40 31/9 -- 100Carty 1997 67 58/9 42/25 99Irvin 1994 18 18/0 -- 89Starr 2001 50 38/12 0/50 92

Page 18: Evolution of Parathyroid Surgery Using Sestamibi Imaging Guidance David R. Byrd, MD Department of Surgery University of Washington

Minimally Invasive Radioguided Parathyroidectomy (MIRP)

• only in patients who localize by pre-op sestamibi scan (75% with primary HPT)

• sestamibi scan performed 2-3 hours before exploration - timing crucial

• gamma probe used to find the “hottest” spot• ex vivo adenoma counts >20% background• no further dissection and no frozen section• if no adenoma found, 4 gland exploration

-Norman J, et al, 1997

Page 19: Evolution of Parathyroid Surgery Using Sestamibi Imaging Guidance David R. Byrd, MD Department of Surgery University of Washington
Page 20: Evolution of Parathyroid Surgery Using Sestamibi Imaging Guidance David R. Byrd, MD Department of Surgery University of Washington
Page 21: Evolution of Parathyroid Surgery Using Sestamibi Imaging Guidance David R. Byrd, MD Department of Surgery University of Washington
Page 22: Evolution of Parathyroid Surgery Using Sestamibi Imaging Guidance David R. Byrd, MD Department of Surgery University of Washington
Page 23: Evolution of Parathyroid Surgery Using Sestamibi Imaging Guidance David R. Byrd, MD Department of Surgery University of Washington

MIRP - results

• 2 cm incision• local w/ sedation, out-patient procedure• 100% cure rate• no complications• mean operating time = 25 minutes• re-operative cure rate = 100%

-Norman J, 1997

Page 24: Evolution of Parathyroid Surgery Using Sestamibi Imaging Guidance David R. Byrd, MD Department of Surgery University of Washington

Studies of MIRP in HPT

solitary/ Uni/bilat. Cure rate # pts MGD exploration ( %)

Martinez 3 2/1 -- --Gallowitsch 12 -- -- --Bonjer 62 49/10 -- 95Norman 15 15/0 14/1 --Norman 24 21/0 21/1 --Flynn 39 32/6 30/9 100

Page 25: Evolution of Parathyroid Surgery Using Sestamibi Imaging Guidance David R. Byrd, MD Department of Surgery University of Washington

Evolution of Surgery for Primary HPT

• Preoperative sestamibi in all patients with primary HPT:– help decision whether to operate in selected patients

– localize adenoma to plan localized exploration

• Minimally invasive parathyroidectomy (MIP):– 2-4 cm incision

– often w/ local + sedation

– out-patient procedure

– +/- IOPTH testing - biochemical confirmation

• Endoscopic removal of parathyroid gland(s)

Page 26: Evolution of Parathyroid Surgery Using Sestamibi Imaging Guidance David R. Byrd, MD Department of Surgery University of Washington

Right inferior parathyroid adenoma - 54F

15 min Ant 1 hr Ant 1 hr RAO

adenoma

Page 27: Evolution of Parathyroid Surgery Using Sestamibi Imaging Guidance David R. Byrd, MD Department of Surgery University of Washington

IOPTH Testing and Results

Baseline #1 214

Baseline #2 157

5 minute post 32

10 minutes post 20

MIP findings - 500mg L inferior pole adenoma

F/U levels 3 mos: Ca++ = 9.5, PTH = 55 (both normal)

Page 28: Evolution of Parathyroid Surgery Using Sestamibi Imaging Guidance David R. Byrd, MD Department of Surgery University of Washington

Case # 3

50M, asymptomatic:- serum Ca++ = 13.4- preop iPTH = 750- concern for carcinoma

Page 29: Evolution of Parathyroid Surgery Using Sestamibi Imaging Guidance David R. Byrd, MD Department of Surgery University of Washington

Tc-99m sestamibi positive for intense uptake LIP

Immed Ant Delay Ant

Page 30: Evolution of Parathyroid Surgery Using Sestamibi Imaging Guidance David R. Byrd, MD Department of Surgery University of Washington
Page 31: Evolution of Parathyroid Surgery Using Sestamibi Imaging Guidance David R. Byrd, MD Department of Surgery University of Washington

IOPTH Testing and Results

Baseline #1 1259

Baseline #2 764

5 minute post 129

10 minutes post 93

Case #3: 50M, 4.2 LIP gm adenoma

Early F/U: Ca++ =8.8, PTH = 138 (low calcium, sl. elevated PTH)

Page 32: Evolution of Parathyroid Surgery Using Sestamibi Imaging Guidance David R. Byrd, MD Department of Surgery University of Washington

Operation for Tertiary HPT

• standard operation remains 3 1/2 gland removal or total parathyroidectomy w/ auto transplant dorsal forearm

• Imaging not standard at present• selected patients may benefit from Tc-99m

sestamibi preop scan• role of IOPTH testing evolving

Page 33: Evolution of Parathyroid Surgery Using Sestamibi Imaging Guidance David R. Byrd, MD Department of Surgery University of Washington